viral vectors

FDA
Pharma

FDA restricts bluebird's gene therapy after blood cancer reports

The restriction comes after an increase in blood cancer cases that are linked to the lentiviral vector of Skysona triggered an FDA investigation.
Angus Liu Aug 8, 2025 11:19am
FDA

FDA investigates 2 deaths after Sarepta Duchenne gene therapy

Jun 25, 2025 10:26am
Redbrick building with Sarepta name and logo

2nd patient dies after Sarepta's DMD gene therapy Elevidys

Jun 16, 2025 10:58am
Bristol Myers Squibb

BMS calls it quits on vector production at former Novartis plant

May 2, 2025 11:20am
thunderstorm road

Patient dies after receiving Sarepta's DMD gene therapy Elevidys

Mar 18, 2025 10:34am
Novartis

Novartis debuts €40M viral vector plant in Slovenia

Feb 10, 2025 10:57am